Cancer BiologybioRxivPreprint
A cell competition-based drug screen identifies a novel compound that induces dual c-Myc depletion and p53 activation
D. S. Tadele, J. M. Robertson, R. Crispin…·J. M. Enserink
This study identifies a novel compound, DJ34, that depletes c-Myc and activates p53, showing strong activity against leukemic stem cells across multiple cancer types.
DOI 10.1101/2020.05.16.089755